Octreotide for the Treatment of Hypoglycemia After Insulin Glargine Overdose

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

Mauro Lepore, Simone Pampanelli, Carmine G. Fanelli et al. · Diabetes · 2000 · 820 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo.

L Heinemann, R. Linkeschova, Klaus Rave et al. · Diabetes Care · 2000 · 477 citations · Full text

Medicine, Endocrinology, Pharmacology +15

Octreotide: An antidote for sulfonylurea-induced hypoglycemia

Steven A. McLaughlin, Cameron Crandall, Patrick E. McKinney · Annals of Emergency Medicine · 2000 · 154 citations

Medicine, Endocrinology, Pharmacology +11

Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses.

P J Boyle, Keith M Justice, Andrew J. Krentz et al. · The Journal of Clinical Endocrinology & Metabolism · 1993 · 113 citations

Medicine, Endocrinology, Pharmacology +16

Insulin Overdose in Eight Patients

Ridha Arem, William A. Zoghbi · Medicine · 1985 · 87 citations

Medicine, Endocrinology, Diabetology +6